Financial Freedom LLC’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Financial Freedom LLC’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-388	Closed	-$40.2K	–	316
2026 Q1	$40.2K	Buy	388 +1	+0.3%	+$106	0.02%	182
2025 Q4	$40.4K	Buy	387 +1	+0.3%	+$101	0.02%	176
2025 Q3	$35.7K	Buy	386 +1	+0.3%	+$88	0.02%	186
2025 Q2	$30.7K	Buy	385 +2	+0.5%	+$160	0.02%	195
2025 Q1	$33.2K	Buy	383 +1	+0.3%	+$85	0.02%	190
2024 Q4	$31.6K	Buy	382 +1	+0.3%	+$86	0.02%	187
2024 Q3	$33.2K	Sell	381 -51	-12%	-$4.36K	0.02%	186
2024 Q2	$35.6K	Buy	432 +53	+14%	+$4.21K	0.02%	181
2024 Q1	$30.4K	Hold	379	–	–	0.02%	189
2023 Q4	$28.8K	Buy	379 +1	+0.3%	+$71	0.02%	193
2023 Q3	$27.3K	Buy	378 +1	+0.3%	+$77	0.02%	190
2023 Q2	$28.5K	Buy	377 +1	+0.3%	+$76	0.02%	187
2023 Q1	$28.6K	Buy	376 +1	+0.3%	+$77	0.02%	184
2022 Q4	$29.5K	Buy	+375	New	+$28.8K	0.02%	178

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

JGCM

Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

Financial Freedom LLC's PJP Position: Q2 2026 in Review

Financial Freedom LLC sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2026, closing a stake of 388 shares — an estimated $40.2K sold.

Financial Freedom LLC first reported a position in PJP in Q4 2022 and held it in 14 quarters. The position peaked at $40.4K in Q4 2025. 116 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

Financial Freedom LLC reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2026 after selling out during the quarter.
Financial Freedom LLC sold 388 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $40.2K.
Financial Freedom LLC first reported a position in Invesco Pharmaceuticals ETF in Q4 2022 and held it in 14 quarters.
Financial Freedom LLC's Invesco Pharmaceuticals ETF position peaked at $40.4K in Q4 2025.
116 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Financial Freedom LLC's 13F filing for Q2 2026, filed 6 Aug 2026.